00:31:12

Patient Power Insights from the Front Lines of Myeloma

Presented By: Bristol Myers Squibb  Mariana Broussard  Associate Director, Global Patient Advocacy, Multiple Myeloma  Dr. Brian Englehart, MD, MSCI  Multiple Myeloma Medical Engagement Lead   Robert Pugh  Long-Term Multiple Myeloma Survivor Patient...

Black Representation in The Fight against Multiple Myeloma.

In the U.S., African Americans are about 14% of the country’s population, but they constitute about 20% of all myeloma patients. And that incidence is actually growing. This is an enormous burden, considering 1 in every 5 patients diagnosed with multiple myeloma in the U.S. is African American.

According to Myeloma.org, it is predicted that by 2034, 1 of 4 myeloma patients will be of African descent, and 24% of the newly diagnosed myeloma population will be African American.

FAQ - Frequently Asked Questions

What disparities do African Americans with Myeloma face?

The Black community often sees disparities in receiving fewer transplants, needing more blood product transfusions, receiving fewer palliative care consultations, less inpatient chemotherapy, and more use of intensive care.

The Importance of Clinical Research for Patients With Multiple Myeloma

Clinical research is critical in developing new therapies for multiple myeloma, a rare and incurable blood cancer that frequently returns after successful treatment. Multiple myeloma...

MORE RESOURCES FOR MYELOMA

00:31:12

Patient Power Insights from the Front Lines of Myeloma

Presented By: Bristol Myers Squibb  Mariana Broussard  Associate Director, Global Patient Advocacy, Multiple Myeloma  Dr. Brian Englehart, MD, MSCI  Multiple Myeloma Medical Engagement Lead   Robert Pugh  Long-Term Multiple Myeloma Survivor Patient...

How Telehealth Can Help Us Fight Blood Cancer

Could telemedicine help support those in Black communities battling blood cancers like multiple myeloma? New research says yes, but time is running out to...